Review Article
Somatostatin Receptor-Based Molecular Imaging and Therapy for Neuroendocrine Tumors
Table 1
Characteristics of radionuclides used for SRI and PRRT.
| Radionuclide | Type of decay | Type of rays | Half-life | Energy | Producer |
|
111In | EC | | 2.8 days | 173 KeV |
111Cd (p, n) | | | | 247 KeV | |
18F | β+ | | 109.8 min | 511 KeV |
20Ne (d, ) | EC | | | |
18O (p, n) |
68Ga | β+ | | 68.3 min | 511 KeV |
68Ge-68Ga generator |
90Y | β− | | 64 h | 2.288 MeV |
90Sr-90Y generator |
177Lu | β− | | 6.7 days | 0.5 MeV |
176Lu (n, γ) | | | | | |
176Yb (n, γ) |
64Cu | β− | | 12.7 h | 0.58 MeV |
63Cu (n, γ) | β+ | | | 0.653 MeV |
64Zn (n, p) | EC | | | 1.346 MeV | |
|
|